Baseline characteristics of the CASTING Study population: a Phase IIIB Trial evaluating Ocrelizumab in patients with relapsing-remitting Multiple Sclerosis and suboptimal response to disease-modifying therapies

Vermersch P., Comi G., SİVA A., Oreja-Guevara C., Wiendl H., Van Wijmeersch B., ...More

4th Congress of the European-Academy-of-Neurology (EAN), Lisbon, Portugal, 16 - 19 June 2018, vol.25, pp.190, (Summary Text) identifier

  • Publication Type: Conference Paper / Summary Text
  • Volume: 25
  • City: Lisbon
  • Country: Portugal
  • Page Numbers: pp.190
  • Istanbul University-Cerrahpasa Affiliated: No